JENNIFER VOSBURG: Open Payments
NPI 1831190321 · ZACHARY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 10 payments from 9 companies in 2025. Trend: 2023 $516 · 2024 $385 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 1 | $37 |
| ABIOMED | 1 | $31 |
| SCPHARMACEUTICALS INC. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: CAMZYOS, Kerendia, ONPATTRO, FUROSCIX, EVKEEZA, LEQVIO, LifeVest, VERQUVO.
Industry payments across LA — which companies pay providers there.
